ID: ALA4788049

Max Phase: Preclinical

Molecular Formula: C15H20O3

Molecular Weight: 248.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCC/C=C/c1cccc(O)c1C(=O)O

Standard InChI:  InChI=1S/C15H20O3/c1-2-3-4-5-6-7-9-12-10-8-11-13(16)14(12)15(17)18/h7-11,16H,2-6H2,1H3,(H,17,18)/b9-7+

Standard InChI Key:  LHIPZDAWLRZGBQ-VQHVLOKHSA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.32Molecular Weight (Monoisotopic): 248.1412AlogP: 4.07#Rotatable Bonds: 7
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.52CX Basic pKa: CX LogP: 5.32CX LogD: 1.81
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.71Np Likeness Score: 1.11

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source